Live Breaking News & Updates on Ionis pharmaceuticals price performance

Stay updated with breaking news from Ionis pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

126,300 Shares in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Purchased by M28 Capital Management LP

M28 Capital Management LP bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 126,300 shares of the company’s stock, valued at approximately $4,770,000. Ionis Pharmaceuticals makes up 4.5% of M28 Capital Management LP’s holdings, making the stock its 6th largest […] ....

United-states , Patrickr-oneil , Delphia-united-states-inc , Citigroup , News-ratings-for-ionis-pharmaceuticals-daily , Needham-company , Profund-advisors , Quarter-for-ionis-pharmaceuticals , Ionis-pharmaceuticals-price-performance , Lincoln-national-corp , Commerce-bank

MQS Management LLC Takes Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

MQS Management LLC acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,547 shares of the company’s stock, valued at approximately $247,000. A number of other institutional investors and hedge […] ....

Canada , Sanfordc-bernstein , Nasdaq , Barclays , Tweedy-browne-co , Clearbridge-investments , Royal-bank , Exchange-commission , Ionis-pharmaceuticals-price-performance , Ionis-pharmaceuticals-inc , Mqs-management

Tweedy Browne Co LLC Acquires 818,148 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Tweedy Browne Co LLC raised its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 30.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,541,136 shares of the company’s stock after buying an additional 818,148 shares during the quarter. Ionis Pharmaceuticals accounts for […] ....

Canada , Almanack-investment-partners , Ionis-pharmaceuticals , Ionis-pharmaceuticals-price-performance , News-ratings-for-ionis-pharmaceuticals-daily , Wipfli-financial-advisors , Ionis-pharmaceuticals-company-profile , Nasdaq , Ionis-pharmaceuticals-inc , Quarter-for-ionis-pharmaceuticals , Tweedy-browne-co

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Hold" from Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has been assigned an average recommendation of “Hold” from the fourteen brokerages that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and five have issued a buy recommendation on the […] ....

Sanfordc-bernstein , Eric-swayze , Piper-sandler , Tweedy-browne-co , News-ratings-for-ionis-pharmaceuticals-daily , Securities-exchange-commission , Nasdaq , Ionis-pharmaceuticals-price-performance , T-rowe-price-investment-management-inc , Vanguard-group-inc , Ionis-pharmaceuticals , Morgan-stanley

AtonRa Partners Decreases Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

AtonRa Partners reduced its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 21.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,875 shares of the company’s stock after selling 3,753 shares during the period. AtonRa Partners’ holdings in […] ....

Canada , Eric-swayze , Piper-sandler , Patrickr-oneil , Algert-global , Ionis-pharmaceuticals , Royal-bank , Quarter-for-ionis-pharmaceuticals , Ionis-pharmaceuticals-price-performance , Exchange-commission , Morgan-stanley , News-ratings-for-ionis-pharmaceuticals-daily